BACKGROUND A strong cumulative effect of five genetic variants and family history on
prostate cancer risk was recently reported in a Swedish population (CAPS). We carried out …

To search for genetic variants that are associated with prostate cancer risk in the genome,
we combined the data from our genome-wide association study (GWAS) in a population …

BACKGROUND Multiple DNA sequence variants in the form of single‐nucleotide
polymorphisms (SNPs) have been found to be reproducibly associated with prostate cancer …

PURPOSE: Five genetic variants along chromosomes 8q24 and 17q have a cumulative
association with prostate cancer risk. Our research group previously reported an association …

Background Two prostate cancer genome-wide scans in populations of European ancestry
identified several genetic variants that are strongly associated with prostate cancer risk. The …

Background: Genome-wide association studies have identified multiple genetic variants
associated with prostate cancer risk which explain a substantial proportion of familial relative …

Background Single-nucleotide polymorphisms (SNPs) in five chromosomal regions—three
at 8q24 and one each at 17q12 and 17q24. 3—have been associated with prostate cancer …

A recent genome-wide association study found that genetic variants on chromosomes 3, 6,
7, 10, 11, 19 and X were associated with prostate cancer risk. We evaluated the most …

Polygenic risk scores (PRSs) of common genetic variants have shown promise in prostate
cancer risk stratification, but their validity across populations has yet to be confirmed. We …

Genome-wide association studies have detected more than 30 inherited prostate cancer risk
variants. While clearly associated with risk, their relationship with clinical outcome …